A novel ANT1 gene mutation with probable germline mosaicism in autosomal dominant progressive external ophthalmoplegia

Neuromuscul Disord. 2005 Apr;15(4):311-5. doi: 10.1016/j.nmd.2004.12.004. Epub 2005 Jan 28.

Abstract

Only four different mutations in the adenine nucleotide translocator 1 (ANT1) gene have been found in families with progressive external ophthalmoplegia (PEO). We report a novel heterozygous C to A transversion at nucleotide 269 in the ANT1 gene in a German family with PEO, predicted to convert a highly conserved alanine at codon 90 to aspartic acid. The mutation was identified in three siblings with PEO, one of them additionally suffered from schizoaffective disorder. Microsatellite analysis showed that the mutation was dominant and inherited from the mother who did not carry the mutation in blood, indicating germ-line mosaicism.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine Nucleotide Translocator 1 / genetics*
  • Aged
  • Aged, 80 and over
  • Alanine / genetics
  • Animals
  • Aspartic Acid / genetics
  • Blotting, Southern / methods
  • DNA Mutational Analysis / methods
  • Electron Transport Complex IV / metabolism
  • Family Health
  • Female
  • Germ-Line Mutation*
  • Humans
  • Male
  • Middle Aged
  • Mosaicism*
  • Muscles / metabolism
  • Muscles / pathology
  • Ophthalmoplegia, Chronic Progressive External / genetics*
  • Pedigree
  • RNA, Messenger / biosynthesis
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Sequence Analysis, Protein / methods
  • Succinate Dehydrogenase / metabolism

Substances

  • Adenine Nucleotide Translocator 1
  • RNA, Messenger
  • Aspartic Acid
  • Succinate Dehydrogenase
  • Electron Transport Complex IV
  • Alanine